Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
Open Forum Infectious Diseases · 04.04.2023 · 10 (4)
DOI: 10.1093/ofid/ofad164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 28.03.2023. Verfasst von Amalia Anastasopoulou und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine, Laikon General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cytomegalovirus (CMV) infection/disease has been repeatedly reported in patients treated with immune-checkpoint inhibitors (ICIs) and most commonly involves patients with relapsed/refractory (R/R) immune-related adverse events (irAEs). In the current study, we present a patient with melanoma who developed CMV gastritis during treatment with pembrolizumab in the absence of irAEs and without previous or current immunosuppression. Moreover, we review the literature regarding CMV infection/disease in patients treated with ICIs for solid malignancies. We present the currently available data on the pathogenesis, clinical characteristics, endoscopic findings, and histologic features and highlight the potential differences among cases complicating R/R irAEs versus those occurring in patients who are immunosuppression naive. Finally, we discuss the currently available data regarding potential useful diagnostic tools as well as the management of these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Internal Medicine, Laikon General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
- Department of Pathology, Evaggelismos Hospital, Athens, Greece.
- Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
ORCID-Profile: Amalia Anastasopoulou
Zitieren
APA
Anastasopoulou, A., Samarkos, M., Diamantopoulos, P., Vourlakou, C., Ziogas, D. C., Avramopoulos, P., Kouzis, P., Haanen, J., & Gogas, H. (2023). Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies. Open Forum Infectious Diseases, 10(4). https://doi.org/10.1093/ofid/ofad164
Vancouver
Anastasopoulou A, Samarkos M, Diamantopoulos P, Vourlakou C, Ziogas DC, Avramopoulos P, et al. Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies. Open Forum Infectious Diseases. 2023;10(4). doi:10.1093/ofid/ofad164
BibTeX
@article{Anastasopoulou2023,
author = {Anastasopoulou, Amalia and Samarkos, Michael and Diamantopoulos, Panagiotis and Vourlakou, Christina and Ziogas, Dimitrios C and Avramopoulos, Pantelis and Kouzis, Panagiotis and Haanen, John and Gogas, Helen},
title = {Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies},
journal = {Open Forum Infectious Diseases},
year = {2023},
volume = {10},
number = {4},
doi = {10.1093/ofid/ofad164}
}
EUVIMED